The presence of NAFLD in nonobese subjects increased the risk of metabolic abnormalities than obese subjects without NAFLD: a population-based cross-sectional study

Abstract

Background: With lifestyle modification and over-nutrition, the prevalence of nonalcoholic fatty liver disease (NAFLD) has been increasing annually. Here we aimed to assess the updated prevalence of NAFLD, and to evaluate the association of NAFLD with metabolic abnormalities according to gender, body mass index and age.Methods: A population-based cross-sectional study was conducted in Shanghai from December 2016 to July 2017. With a three-stage stratified sampling strategy, 3,717 eligible participants were enrolled for the analysis.Results: In total, 1,217 subjects (32.7%) had NAFLD. Among them, 400 (16.3%) of the nonobese and 817 (65.0%) of the obese subjects had NAFLD. The prevalence of NAFLD was increased according to the quartiles of age and waist circumference (WC) in the nonobese subjects. Females with nonobese NAFLD had 1.6-, 2.6-, 2.0-, 2.3-and 3.3-fold higher risks for metabolic syndrome, diabetes mellitus, hyperglycemia, hypertriglycerdemia (high TG) and low high-density lipoprotein cholesterol than obese subjects without NAFLD, respectively. Males had comparable metabolic profiles in both groups, except for a 2.0-fold higher risk of high TG in nonobese NAFLD subjects compared with obese subjects without NAFLD. More impressively, the homeostasis metabolic assessment insulin resistance index was comparable between the two groups.Conclusions: The increase of age and WC had significant impact on the risk of NAFLD in nonobese subjects. The presence of NAFLD in nonobese subjects increased the risk of metabolic diseases than obese subjects without NAFLD, especially in female.

Metastasis of papillary thyroid cancer: does body mass index (BMI) is the key factor?

“…And a meta-analysis ( 5 ) which involved 26,196 participants carried out by Renehan et al also descripted that elevated body mass index (BMI) was significantly associated with ETE and multifocality in overweight and obese patients and only obesity was significantly associated with increased tumor size. The same effect can also be seen in many studies ( 6 , 7 ). Therefore, the aggressiveness of PTC may associated with the increase of BMI, so it is necessary to divide overweight and obese patients in different groups.…”

Lean non-alcoholic fatty liver disease (Lean-NAFLD) and the development of metabolic syndrome: a retrospective study

“…1 , the Kaplan–Meier curves showed the higher cumulative incidence of MS in lean NAFLD population than that in obesity/overweight non-NAFLD subjects. In a recent, Hu et al’s cross-sectional study also found that lean NAFLD present higher MS risk than overweight/obese non-NAFLD 24 . Two possible reasons may account for this phenomenon.…”

“…Two possible reasons may account for this phenomenon. One reason is that lean NAFLD is more likely a specific metabolic disease that is stronger correlated with MS than obesity 24 . Another one is the limitation of BMI in reflection of abdominal fat.…”

Serum pancreatic amylase and colorectal adenoma: From clinical research to practice

“…3 Longer duration and severity of NAFLD has been associated with increased risk of metabolic abnormalities. 4 However, the detailed degree of NAFLD was not reported in this study. Moreover, a recent study showed that increase in visceral adiposity was associated with a higher risk for CRA, indicating there might also be changes in the severity of NAFLD.…”